3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile - Names and Identifiers
3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile - Physico-chemical Properties
Molecular Formula | C16H20N6O2
|
Molar Mass | 328.38 |
Density | 1.312±0.06 g/cm3(Predicted) |
Boling Point | 640.4±55.0 °C(Predicted) |
Appearance | Solid |
pKa | 6.05±0.60(Predicted) |
Storage Condition | 2-8°C,密封,干燥 |
3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile - Introduction
Tofacitinib metabolite-1 is a metabolite of Tofacitinib, also known as M1 metabolite. Its chemical properties are similar to tofacitinib and it is a small organic compound. Tofacitinib metabolite-1 is widely used in the medical field.
Tofacitinib metabolite-1 is commonly used as a targeted treatment for tumors. It can inhibit the growth and division of tumor cells by binding to specific receptors of tumor cells, thus playing a role in the treatment of tumors.
Tofacitinib metabolite-1 is generally produced by the metabolism of Tofacitinib in the body. The specific preparation method is to metabolize Tofacitinib through the liver to form Tofacitinib metabolite-1.
Last Update:2024-04-09 01:59:58